We are pleased to share that Argus Partners has advised Zeno Health, a health-tech startup and omnichannel pharmacy platform for generic and branded medicines, on raising $25 Million in its Series C funding round. The funding round was led by South Korean private equity investor STIC Investments, with significant participation from existing investor, Lightbox Ventures.
Zeno Health aims to utilize the latest capital infusion to expand its footprint and enhance its technological infrastructure. Further, the investment will also empower Zeno Health, in making quality healthcare affordable to all and serve nearly 1 (one) crore consumers monthly.
As per Siddharth Gadia, Co-founder and CEO at Zeno Health, “We are thrilled to welcome STIC as a key partner in our journey. Their investment, coupled with the continued commitment from Lightbox, signifies a resounding endorsement of our mission to make quality healthcare affordable to all. The company remains steadfast in its mission to reach and serve 1 crore consumers monthly, aspiring to reduce their healthcare expenditure by 50%.”
Also, sharing his views on the funding round, Derrick (Kihyun) Yun, managing director of STIC, said, "Zeno Health has demonstrated a remarkable commitment to reshaping the healthcare landscape in India. Their vision aligns with our values, and we look forward to contributing to their journey towards making quality healthcare accessible across India.”
The Argus Team consisted of Abhinav Bhalaik and Neha Madan (Partners) and Rohan Aneja, Abhishek Tripathy and Tanya Nair (Associates).